PharmaShots | Incisive News in 3 Shots

Subscribe Now

Lyell Immunopharma

Lyell Immunopharma’s LYL845 Receives the US FDA’s Orphan Drug Designation to Treat Melanoma

Lyell Immunopharma’s LYL845 Receives the US FDA’s Orphan Drug Designation to Treat Melanoma

November 10, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us